Noxopharm Limited 46 Note 22. Interests in subsidiaries and associates The consolidated financial statements incorporate the assets, liabilities and results of the following subsidiaries in accordance with the accounting policy described in note 1: Ownership interest Principal place of business / 2022 2021 Name Country of incorporation % % Norbio Holding Pty Ltd Australia 100.00% 100.00% Pharmorage Pty Limited Australia 100.00% 100.00% Note 23. Matters subsequent to the end of the financial year No matter or circumstance has arisen since 30 June 2022 that has significantly affected, or may significantly affect the consolidated entity’s operations, the results of those operations, or the consolidated entity’s state of affairs in future financial years.
RkJQdWJsaXNoZXIy MjE2NDg3